Recent results from niacin trial for unmethalayted glioblastoma

November 10, 2026Written by Navis AI

TL;DR: Niacin (a B vitamin) is being studied in clinical trials for unmethylated glioblastoma, but results are still emerging—talk to your doctor about whether this trial might be right for you.

KEY POINTS:

  • Unmethylated glioblastoma is a subtype of brain tumor that tends to be more aggressive and harder to treat than methylated forms
  • Niacin trials represent an emerging approach, but this is still experimental research—not yet standard treatment
  • Clinical trial results help doctors understand if new treatments work better than current options
  • Your neuro-oncologist can tell you if you're eligible for niacin trials and how they compare to your current treatment plan
  • Finding the right clinical trial requires matching your specific tumor type, genetics, and health status with available studies

NEXT STEP: Ask your neuro-oncologist: "Are there any niacin or other clinical trials available for my unmethylated glioblastoma, and would I be a good candidate?"


[[FULL_ANSWER]]

Tell us what’s going on with your cancer. 2 free answers, then a free account.

Understanding Unmethylated Glioblastoma and Niacin Trials

I want to help you understand what niacin trials mean for unmethylated glioblastoma, but I should be upfront: I don't have access to the specific recent niacin trial results you're referring to. However, I can explain the context and help you ask the right questions.

What Is Unmethylated Glioblastoma?

Glioblastoma (GBM) is the most aggressive type of brain tumor. Doctors now know that glioblastomas come in different molecular subtypes based on genetic markers—one of the most important being methylation status of a gene called MGMT.

Unmethylated glioblastoma means:

  • The MGMT gene is NOT methylated (a chemical modification that normally protects DNA)
  • This subtype is generally more aggressive and tends to respond less well to standard chemotherapy (temozolomide/Temodar)
  • Patients with unmethylated tumors often have shorter survival times than those with methylated tumors
  • This is why researchers are actively looking for new treatment approaches for this subtype

According to the Musella Foundation's Brain Tumor Guide for the Newly Diagnosed, molecular evaluation—including understanding these genetic markers—is a critical part of your diagnostic process and helps guide treatment decisions.

What Are Niacin Trials and Why Study Them?

Niacin (also called nicotinic acid or vitamin B3) is being investigated because:

  • Some research suggests niacin may have anti-tumor properties or may enhance the immune system's ability to fight cancer
  • It's a relatively safe, well-tolerated compound with a long history of use
  • Researchers are exploring whether it might work better for aggressive subtypes like unmethylated GBM

However, niacin trials for glioblastoma are still experimental—meaning:

  • Results are still being collected and analyzed
  • We don't yet know if niacin will be more effective than current standard treatments
  • It's not yet approved as a standard treatment by the FDA for brain tumors

How Clinical Trials Work (And Why They Matter)

According to the Musella Foundation, clinical trials are essential because they:

  • Test whether new treatments actually work better than current options
  • Help doctors understand which patients benefit most from which treatments
  • Provide access to cutting-edge therapies that aren't yet widely available
  • Contribute to advancing treatment for future patients

If you're considering a niacin trial, you'd typically:

  1. Meet with your neuro-oncologist to discuss eligibility
  2. Review the trial's protocol (the detailed plan for how the study works)
  3. Understand the potential benefits and risks
  4. Sign informed consent (agreeing to participate with full knowledge)
  5. Receive regular monitoring and follow-up imaging

Questions to Ask Your Neuro-Oncologist

Since I don't have the specific recent trial results, here are the key questions that will help you understand whether a niacin trial is right for you:

  1. "What are the latest results from niacin trials for unmethylated glioblastoma? How do they compare to standard treatment?"

    • This gets you the actual data your doctor is seeing
  2. "Am I eligible for any niacin trials based on my tumor's molecular profile and my current health status?"

    • Eligibility depends on many factors beyond just tumor type
  3. "How would a niacin trial fit into my overall treatment plan? Would it replace, supplement, or follow my current treatment?"

    • Understanding the sequence and combination of treatments matters
  4. "What are the potential side effects of niacin, and how would they be monitored?"

    • Even "natural" compounds can have side effects
  5. "If I enter a trial and it's not working, what's my backup plan?"

    • You need to know your options if the experimental approach doesn't help
  6. "Where can I find information about available trials, and how do I apply?"

    • Your doctor can help, but you can also search ClinicalTrials.gov independently

Where to Find Clinical Trial Information

According to the Musella Foundation, excellent resources for finding clinical trials include:

  • ClinicalTrials.gov (the National Institutes of Health database)
  • VirtualTrials.org (the Musella Foundation's specialized brain tumor trial database)
  • Your neuro-oncologist's institution (many major cancer centers have their own trials)
  • The National Cancer Institute (NCI) website

The Musella Foundation emphasizes that when assessing a clinical trial, you should consider:

  • The trial's phase (Phase 1, 2, or 3—earlier phases are more experimental)
  • Eligibility criteria (do you qualify?)
  • The trial's location and time commitment
  • What happens after the trial ends
  • How results will be monitored and shared with you

Important Context: Standard Treatment for Unmethylated GBM

While niacin trials are emerging, current standard treatment for glioblastoma typically includes:

  • Surgery (maximum safe resection of the tumor)
  • Radiation therapy (usually 6 weeks of daily treatments)
  • Chemotherapy (temozolomide/Temodar, often given during and after radiation)
  • Optune/TTFields (a newer FDA-approved device that may help some patients)
  • Bevacizumab (Avastin) (an anti-angiogenesis drug used in some cases)

For unmethylated tumors specifically, your doctor may recommend more aggressive approaches or earlier consideration of clinical trials because standard treatments are less effective.

The Bottom Line

Niacin trials represent hope and innovation—researchers are actively working to find better treatments for aggressive glioblastomas. However:

  • Results are still emerging
  • This is experimental, not yet standard care
  • Your specific eligibility and fit for a trial depends on your complete medical picture
  • Your neuro-oncologist is your best resource for understanding how this applies to YOU

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated November 10, 2026. Informational only — not a substitute for your oncology team.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Services

Services that may help with clinical trials for cancer patients

More questions about General